Upsher-Smith Laboratories Announces Initiation Of Phase III Clinical Trial Of USL255 (Extended-Release Topiramate)
Links shared publicly online about this topic.
- 1,090total visits
Upsher-Smith Laboratories Announces Initiation Of Phase III Clinical Trial Of USL255 (Extended-Release Topiramate)
View full resource at medicalnewstoday.com
Tags: Migraine Prevention Medication, Seizure Medication, Clinical Trial, Topamax, Epilepsy Medication
Most Recently Shared on June 17, 2010 at 3:04 am By:
Upsher-Smith Laboratories Announces Initiation Of Phase III Clinical Trial Of USL255 (Extended-Release Topiramate) http://mnt.to/3DWg
Also Shared By:
Upsher-Smith Laboratories Announces Initiation Of Open-Label Extension Study Of USL255 (Extended-Release Topiramate) For Partial Onset Epilepsy
medicalnewstoday.com — “Upsher-Smith Laboratories, Inc. announced the addition of an open-label extension study to PREVAIL, its global Phase III clinical trial for USL255 (extended-release topiramate). An internally deve” View full resource at medicalnewstoday.com
Most Recently Shared on November 10, 2010 at 5:05 pm By:
Upsher-Smith Laboratories Announces Initiation Of Open-Label Extension Study Of USL255 (Extended-Release Topiramate) F... http://mnt.to/3Mmt
Upsher-Smith commences global USL255 Phase III clinical trial for management of epilepsy
news-medical.net — “Upsher-Smith Laboratories, Inc. today announced the initiation of a global Phase III clinical trial for USL255 (extended-release topiramate), an internally developed program for the management of epilepsy in adults, using the company's proprietary formulation technology. USL255 is designed to provide convenient once-daily dosing and reduce fluctuations in topiramate blood levels observed with currently available topiramate options.” View full resource at news-medical.net
Most Recently Shared on June 14, 2010 at 7:13 pm By:
Epilepsy News: Upsher-Smith commences global USL255 Phase III clinical trial for management of epilepsy: Upsher-Sm... http://bit.ly/cl5PFS
Advertisement
Epilepsy OW
@Epilepsy_Wisdom
Upsher-Smith Laboratories Announces Initiation Of Phase III Clinical Trial Of USL255 (Extended-Release Topiramate)... http://mnt.to/f/3DWg
1 year ago...